Investigating diabetes risk in patients with acute pancreatitis
Southern California Clinical Center of the Type 1 Diabetes in Acute Pancreatitis Consortium
['FUNDING_U01'] · CEDARS-SINAI MEDICAL CENTER · NIH-10911218
This study is looking at how having acute pancreatitis might lead to different kinds of diabetes, and it's for people who have had this condition; by checking their insulin and sugar levels, researchers hope to find clues that could help prevent diabetes from developing after pancreatitis.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CEDARS-SINAI MEDICAL CENTER (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10911218 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how acute pancreatitis (AP) can lead to different types of diabetes, including autoimmune forms. Patients who have experienced AP or recurrent AP will be recruited to undergo a series of tests that measure their insulin and glucose levels over time. The study aims to identify the metabolic and genetic factors that contribute to diabetes development in these patients. By closely monitoring these individuals, researchers hope to uncover patterns that could help predict and prevent diabetes after AP.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who have recently experienced an episode of acute pancreatitis or recurrent acute pancreatitis and are currently non-diabetic.
Not a fit: Patients who have already been diagnosed with diabetes or those who have not experienced acute pancreatitis will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for diabetes that develops after acute pancreatitis.
How similar studies have performed: Previous research has shown promising results in understanding diabetes mechanisms in similar patient populations, indicating that this approach has potential for success.
Where this research is happening
LOS ANGELES, UNITED STATES
- CEDARS-SINAI MEDICAL CENTER — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOODARZI, MARK — CEDARS-SINAI MEDICAL CENTER
- Study coordinator: GOODARZI, MARK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus, Brittle Diabetes Mellitus